Researchers watch how doctors treat High-Risk breast cancer in daily practice
NCT ID NCT07151911
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 28 times
Summary
This study follows 100 adults with high-risk, hormone-sensitive early breast cancer to see which treatments doctors choose in real life. Participants take their prescribed medications and fill out questionnaires about their quality of life. The goal is to understand current treatment patterns, not to test a new drug. Each person will be tracked for up to 5 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Ospedaliero Universitaria Policlinico di Modena
RECRUITINGModena, Modena, 41124, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.